Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Carter

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Urology|November 1, 1989
Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface chargeH B Carter, A W Partin, D S Coffey
Urology|December 1, 1987
Variables influencing radiation exposure during extracorporeal shock wave lithotripsy. Review of 298 treatmentsH B Carter, E B Näslund, R A Riehle
Urology|January 14, 1999
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseH B Carter, J I Epstein, A W Partin
The Journal of Urology|November 4, 2000
Is preoperative donation of autologous blood rational for radical retropubic prostatectomy?B Goldschlag, N Afzal, H B Carter, et al.
Urology|May 19, 2001
Effect of local anesthetics on patient recovery after transrectal biopsyC L Wu, H B Carter, M Naqibuddin, et al.
The Journal of Urology|October 19, 1999
The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancerJ I Epstein, P C Walsh, G Akingba, et al.
The Journal of Urology|October 23, 1997
Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancerJ I Epstein, P C Walsh, J Sauvageot, et al.
The Journal of Urology|June 1, 1997
Prospective evaluation of men with stage T1C adenocarcinoma of the prostateH B Carter, J Sauvageot, P C Walsh, et al.
JAMA|September 16, 2000
Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detectionK S Ross, H B Carter, J D Pearson, et al.
European Urology|May 8, 2001
Expectant management of prostate cancer with curative intentH B Carter, P K Landis, J I Epstein, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Urology|November 1, 1989
Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface chargeH B Carter, A W Partin, D S Coffey
Urology|December 1, 1987
Variables influencing radiation exposure during extracorporeal shock wave lithotripsy. Review of 298 treatmentsH B Carter, E B Näslund, R A Riehle
Urology|January 14, 1999
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseH B Carter, J I Epstein, A W Partin
The Journal of Urology|November 4, 2000
Is preoperative donation of autologous blood rational for radical retropubic prostatectomy?B Goldschlag, N Afzal, H B Carter, et al.
Urology|May 19, 2001
Effect of local anesthetics on patient recovery after transrectal biopsyC L Wu, H B Carter, M Naqibuddin, et al.
The Journal of Urology|October 19, 1999
The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancerJ I Epstein, P C Walsh, G Akingba, et al.
The Journal of Urology|October 23, 1997
Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancerJ I Epstein, P C Walsh, J Sauvageot, et al.
The Journal of Urology|June 1, 1997
Prospective evaluation of men with stage T1C adenocarcinoma of the prostateH B Carter, J Sauvageot, P C Walsh, et al.
JAMA|September 16, 2000
Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detectionK S Ross, H B Carter, J D Pearson, et al.
European Urology|May 8, 2001
Expectant management of prostate cancer with curative intentH B Carter, P K Landis, J I Epstein, et al.
Pageof 10